Cleared Traditional

K133382 - QB TEST (FDA 510(k) Clearance)

K133382 · Qbtech AB · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2014
Decision
140d
Days
-
Risk

K133382 is an FDA 510(k) clearance for the QB TEST. Classified as Recorder, Attention Task Performance (product code LQD).

Submitted by Qbtech AB (Stockholm, SE). The FDA issued a Cleared decision on March 24, 2014 after a review of 140 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Qbtech AB devices

Submission Details

510(k) Number K133382 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 04, 2013
Decision Date March 24, 2014
Days to Decision 140 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
8d faster than avg
Panel avg: 148d · This submission: 140d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code LQD Recorder, Attention Task Performance
Device Class -